Close mobile menu×
Close mobile menu

Guarionex Joel DeCastro, MD, MPH

Board Certifications: 
Urology
Expertise in: 
Urologic Oncology, Testicular Cancer, Prostate Cancer, Kidney & Adrenal Cancer, Cancer Care, Bladder Cancer
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-0114

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Urology

Clinical Expertise

  • Urologic Oncology
  • Testicular Cancer
  • Prostate Cancer
  • Kidney & Adrenal Cancer
  • Cancer Care
  • Bladder Cancer
  • Kidney Cancer
  • Laparoscopic Nephrectomy
  • Robotic Prostatectomy
  • Urologic Cancer

Education & Training

  • MD, Columbia University College of Physicians and Surgeons
  • MPH, Columbia University Mailman School of Public Health
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: The University of Chicago Medical Center

About Guarionex DeCastro

Book Appointment

G. Joel DeCastro, MD, MPH, an Assistant Professor of Urology at Columbia University Medical Center. Dr. DeCastro graduated with cum laude honors in Biology from Harvard University in 1997. He then went on to complete his medical school training, a Masters in Public Health, and his Urology residency at Columbia University Medical Center in New York. After residency, he completed a two-year fellowship in Urologic Oncology at the University of Chicago, focused on laparoscopic and robotic surgery. He serves on the review panel of numerous publications, including the Journal of Urology and the Journal of Endourology. He has authored multiple original research articles, book chapters, and editorials on urologic oncology. His present research is primarily on outcomes following treatment for bladder cancer.

Dr. DeCastro is an established expert in both robotic and laparoscopic techniques for treatment of urologic tumors, specifically for bladder, kidney, prostate, and testicular cancer. He sees patients both at the Allen Hospital and at the Herbert Irving Pavillion on the main hospital campus, and participates in most insurance plans.

Academic Titles

  • Assistant Professor of Urology at CUMC

Committee/Societies/Council Memberships

  • American Urological Association
  • Society of Urologic Oncology
  • American Medical Association
  • National Medical Association
  • Society of Endourology

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/The Allen Hospital

Languages

  • French
  • Spanish

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Elderplan

  • Medicare Managed Care

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
5141 Broadway
New York, New York 10034
Phone:
(212) 305-0114
Fax:
(212) 932-4448
Primary
2
161 Fort Washington Avenue
New York, New York 10032
Phone:
(212) 305-0114
Fax:
(212) 305-0129

Research

Grants

PHASE 1/2 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF NANODOCE? INJECTION AND INTRAVESICAL INSTILLATION IN SUBJECTS WITH UROTHELIAL CARCINOMA (P&S Industry Clinical Trial)

Sep 20 2019 - Sep 20 2024

MULTI-INSTITUTIONAL STUDY TO EVALUATE DNA METHYLATION MARKERS FOR DETECTION OF PRIMARY BLADDER CANCERS IN URINE SAMPLES FROM A COHORT OF PATIENTS WITH HEMATURIA (P&S Industry Clinical Trial)

May 22 2017 - May 22 2022

A PHASE 1B, MULTICENTER, OPEN LABEL STUDY EVALUATING SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF GEMRIS 225 MG IN SUBJECTS WITH MUSCLE-INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER (P&S Industry Clinical Trial)

Apr 27 2017 - Apr 27 2022

SUPPORTING SUSTAINABLE IMPLEMENTATION OF HIV AND TB SERVICES FOR EPIDEMIC CONTROL IN THE REPUBLIC OF MOZAMBIQUE UNDER PEPFAR (Federal Gov)

Sep 30 2016 - Sep 29 2021

UROLOGISTS AS POLICY LEADERS: A FUNDAMENTALS IN HEALTH POLICY CURRICULUM (Private)

Jun 1 2018 - Jun 1 2020

INVESTIGATION OF A NONPARTICLE ALBUMIN-BOUND MTOR INHIBITOR, NABRAPAMYCIN, FOR THE INTRAVESICAL TREATMENT OF BCG RECURRENT OR REFRACTORY NON-MUSCLE INVASIVE TRANSITIONAL CELL BLADDER CANCER (Federal Gov)

Apr 1 2013 - Dec 31 2019

INVESTIGATION OF A NONPARTICLE ALBUMIN-BOUND MTOR INHIBITOR, NABRAPAMYCIN, FOR THE INTRAVESICAL TREATMENT OF BCG RECURRENT OR REFRACTORY NON-MUSCLE INVASIVE TRANSITIONAL CELL BLADDER CANCER (Federal Gov)

Apr 1 2013 - Dec 31 2017

EFFICACY OF NAB-REPAMYCIN I THE TREATMENT OF BCG REFRACTORY OR RECURRENT MPM-MUSCLE (Private)

Jul 1 2015 - Aug 31 2016